Literature DB >> 16448546

Role of the transcription factor Th-POK in CD4:CD8 lineage commitment.

Dietmar J Kappes1, Xi He, Xiao He.   

Abstract

The molecular basis of CD4:CD8 lineage commitment, in particular the mechanism by which the precise correlation between lineage choice and T-cell receptor (TCR) specificity toward class I or II major histocompatibility complex is achieved, remains controversial. Both stochastic/selective and instructive models in various forms have been proposed to explain this correlation. The two main experimental approaches previously employed to elucidate this process have focused on the beginning and end of the process, i.e. the influence of TCR signaling and the alternate transcriptional control of the CD4 and CD8 loci during commitment. The recent finding that the transcription factor Th-POK is necessary and sufficient for CD4 commitment has now provided a direct entry point for studying the intracellular pathways that govern lineage commitment. Here, we review data leading to the identification and characterization of this factor and discuss the implications of these studies in the context of current models of lineage commitment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16448546     DOI: 10.1111/j.0105-2896.2006.00344.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  13 in total

Review 1.  Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice.

Authors:  Alfred Singer; Stanley Adoro; Jung-Hyun Park
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

Review 2.  Vertebrate GAF/ThPOK: emerging functions in chromatin architecture and transcriptional regulation.

Authors:  Avinash Srivastava; Amitha Sampath Kumar; Rakesh K Mishra
Journal:  Cell Mol Life Sci       Date:  2017-08-30       Impact factor: 9.261

3.  Beta-catenin regulates positive selection of thymocytes but not lineage commitment.

Authors:  Qing Yu; Jyoti Misra Sen
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

4.  Transcription factor zinc finger and BTB domain 1 is essential for lymphocyte development.

Authors:  Divya Punwani; Karen Simon; Youngnim Choi; Amalia Dutra; Diana Gonzalez-Espinosa; Evgenia Pak; Martin Naradikian; Chang-Hwa Song; Jenny Zhang; David M Bodine; Jennifer M Puck
Journal:  J Immunol       Date:  2012-06-29       Impact factor: 5.422

5.  The transcription factor Th-POK negatively regulates Th17 differentiation in Vα14i NKT cells.

Authors:  Isaac Engel; Meng Zhao; Dietmar Kappes; Ichiro Taniuchi; Mitchell Kronenberg
Journal:  Blood       Date:  2012-10-03       Impact factor: 22.113

6.  Acquisition of a functional T cell receptor during T lymphocyte development is enforced by HEB and E2A transcription factors.

Authors:  Mary Elizabeth Jones; Yuan Zhuang
Journal:  Immunity       Date:  2007-12       Impact factor: 31.745

7.  Disregulated expression of the transcription factor ThPOK during T-cell development leads to high incidence of T-cell lymphomas.

Authors:  Hyung-Ok Lee; Xiao He; Jayati Mookerjee-Basu; Dai Zhongping; Xiang Hua; Emmanuelle Nicolas; Maria Luisa Sulis; Adolfo A Ferrando; Joseph R Testa; Dietmar J Kappes
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-08       Impact factor: 11.205

8.  ZBTB7B (Th-POK) regulates the development of IL-17-producing CD1d-restricted mouse NKT cells.

Authors:  Anselm Enders; Sanda Stankovic; Charis Teh; Adam P Uldrich; Mehmet Yabas; Torsten Juelich; John A Altin; Sandra Frankenreiter; Hannes Bergmann; Carla M Roots; Konstantinos Kyparissoudis; Chris C Goodnow; Dale I Godfrey
Journal:  J Immunol       Date:  2012-10-26       Impact factor: 5.422

Review 9.  GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation.

Authors:  I-Cheng Ho; Tzong-Shyuan Tai; Sung-Yun Pai
Journal:  Nat Rev Immunol       Date:  2009-02       Impact factor: 53.106

Review 10.  CD4 CTL: living up to the challenge.

Authors:  Hilde Cheroutre; Mohammad Mushtaq Husain
Journal:  Semin Immunol       Date:  2013-11-15       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.